Position in NBIX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$45,320,406
+$6,773,282 QoQ
Shares Held
268,900
-8.1% QoQ
Ownership
0.265%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#66
of 768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Swiss National Bank holds $505,151,346 across 28 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
4,121,700 | $139,643,196 | |
| 2 | ZTS |
Zoetis Inc.
|
1,186,032 | $85,228,259 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
111,255 | $60,281,296 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
268,900 | $45,320,406 | |
| 5 | VTRS |
Viatris Inc
|
2,336,402 | $37,102,063 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
1,001,992 | $24,659,023 | |
| 7 | ALKS |
Alkermes plc.
|
316,900 | $16,605,560 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
130,654 | $14,494,754 |
All Filings in NBIX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,320,406 | 268,900 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $38,547,124 | 292,600 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $38,549,394 | 271,800 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $40,050,414 | 285,300 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $37,631,586 | 299,400 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $31,576,300 | 285,500 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $38,943,450 | 285,300 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $34,416,214 | 298,700 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $40,557,582 | 294,600 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $40,576,064 | 294,200 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $40,226,328 | 305,300 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $35,302,500 | 313,800 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $33,212,460 | 352,200 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $38,514,210 | 380,500 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $46,426,328 | 388,700 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $43,995,049 | 414,227 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $40,252,123 | 412,927 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $38,515,031 | 410,827 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $30,629,431 | 359,627 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $35,767,428 | 372,927 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $37,276,187 | 383,027 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $33,133,075 | 340,700 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $32,071,410 | 334,600 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $33,021,344 | 343,400 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $42,309,600 | 346,800 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $29,383,725 | 339,500 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||